null
SMILES O=C(Nc1cc(Nc2ccc3C(=O)NCc3c2)ncn1)C1CC1
InChI Key InChIKey=MIVZVCNGBMCBAA-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 8 hits for monomerid = 297345
TargetMAP kinase-interacting serine/threonine-protein kinase 1(Homo sapiens (Human))
eFFECTOR Therapeutics, Inc.
US Patent
eFFECTOR Therapeutics, Inc.
US Patent
Affinity DataIC50: 10nMAssay Description:Compounds are screened for MNK inhibition using the ADP-Glo kinase assay kit (Promega, catalogue No. V9101). All kinase reactions are performed in Re...More data for this Ligand-Target Pair
TargetMAP kinase-interacting serine/threonine-protein kinase 2(Homo sapiens (Human))
eFFECTOR Therapeutics, Inc.
US Patent
eFFECTOR Therapeutics, Inc.
US Patent
TargetMAP kinase-interacting serine/threonine-protein kinase 2(Homo sapiens (Human))
eFFECTOR Therapeutics, Inc.
US Patent
eFFECTOR Therapeutics, Inc.
US Patent
Affinity DataIC50: 5.70nMAssay Description:Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substr...More data for this Ligand-Target Pair
TargetMAP kinase-interacting serine/threonine-protein kinase 1(Homo sapiens (Human))
eFFECTOR Therapeutics, Inc.
US Patent
eFFECTOR Therapeutics, Inc.
US Patent
Affinity DataIC50: 1.90nMAssay Description:Inhibition of full length GST-tagged recombinant human MNK1 expressed in insect cells using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins ...More data for this Ligand-Target Pair
TargetMAP kinase-interacting serine/threonine-protein kinase 2(Homo sapiens (Human))
eFFECTOR Therapeutics, Inc.
US Patent
eFFECTOR Therapeutics, Inc.
US Patent
TargetMAP kinase-interacting serine/threonine-protein kinase 1(Homo sapiens (Human))
eFFECTOR Therapeutics, Inc.
US Patent
eFFECTOR Therapeutics, Inc.
US Patent
TargetMAP kinase-interacting serine/threonine-protein kinase 1/2(Homo sapiens (Human))
eFFECTOR Therapeutics , 11180 Roselle Street , San Diego , California 92121 , United States.
Curated by ChEMBL
eFFECTOR Therapeutics , 11180 Roselle Street , San Diego , California 92121 , United States.
Curated by ChEMBL
Affinity DataIC50: 430nMAssay Description:Inhibition of MNK1/2 in human HCT116 cells assessed as decrease in eIF4E phosphorylation at Ser209 after 2 hrs by HTRF assayMore data for this Ligand-Target Pair